Zhendong Pharmaceutical, the net profit increased in 2017
Recently, Zhendong Pharmaceutical released a performance report. In 2017, the company achieved operating income of 3.683 billion yuan, an increase of 12.17% year-on-year. The average operating income growth rate of the Chinese medicine industry was 12.42%; the net profit attributable to shareholders of listed companies was 328 million yuan, a year-on-year increase of 61.7%. . Zhendong Pharmaceutical said that with the improvement of residents' health awareness and the impact of industrial policy dividends, the company's business grew steadily, and its Kangyuan Pharmaceutical made a great contribution to the continued growth of its performance. It is reported that Kangyuan Pharmaceutical is one of the largest manufacturers of calcium preparations in China, and its exclusive research and development of Langdi calcium is becoming the mainstream of the market. At present, the annual sales of Langdi calcium is nearly 1.5 billion yuan, surpassing “Caltic†to become the number one brand in China's calcium preparation market, and the compound growth rate has exceeded 30% for several consecutive years. As a pharmaceutical company that started with traditional Chinese medicine preparations, Zhendong Pharmaceutical also has industry leading advantages in the research and development, production and sales of traditional Chinese medicine anti-tumor drugs. The Yanshu injection, which is mainly used for cancer treatment, is the tradition of Zhendong Pharmaceutical. Advantage varieties. In the case of unfavorable overall market environment, the company increased the market share of Yanshu injection in the same category through marketing reform and upgrading of clinical dose, and the market share of anti-tumor Chinese medicine injection reached 5.99%. In the long run, along with the deepening of the sales channels of Zhendong Pharmaceutical in the country and the continuous development of innovative research and development of anti-tumor drugs, Zhendong Pharmaceutical's performance level may usher in a new round of growth. Zhendong Pharmaceutical said that in 2018, Zhendong Pharmaceutical will continue to strengthen the in-depth development and secondary development of existing products based on the three main lines of “product developmentâ€, “scientific research for production services, scientific research for the market†and “international cooperationâ€. Increase market share and inject strong momentum into the future sustainable development of Zhendong Pharmaceutical. Introduction: Organic Red Garlic,Red Garlic Seed,Organic Red Garlic Seed,Fresh Organic Red Garlic Cloves shandong changrong international trade co.,ltd. , https://www.cragriculture.com
The bulb of garlic,an allium plant in the lily family.with the pungent flavor and spicy taste.spherical shape with a diameter of 3-6.5cm. The surface is covered with white and papery-skin.
The top is slightly pointed, with residual scape in the middle,many fibrous root marks at the base. After peeling off the skin, a single head or 6 to 16 petal-shaped small bulbs, inserted around the base of the remaining flower stems. The bulbous valve is slightly ovoid, with a membranous outer skin, slightly pointed at the apex, and an arcuate bulge on one side.
In order to ensure the maximum freshness and nutrients.
We adhere to the traditional natural drying method without any human intervention.
The garlic cultivated and planted according to ecological standards.without the use of chemical agents, the pesticide residues reach the export standards.
Can be stored for long time under proper conditions after sun drying.
With the characteristics of big size,white&distinct appearance,pure flavor,pure flavor,crispy taste,high capsaicin.
Specification
Brand:Changrong
Variety:Liliaceous Vegetables
Color:Purple red